Noesis Capital Mangement’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $234K | Sell |
300
-109
| -27% | -$85K | 0.04% | 116 |
|
2025
Q1 | $338K | Buy |
409
+101
| +33% | +$83.4K | 0.07% | 88 |
|
2024
Q4 | $238K | Buy |
308
+11
| +4% | +$8.49K | 0.05% | 101 |
|
2024
Q3 | $263K | Sell |
297
-10
| -3% | -$8.86K | 0.05% | 101 |
|
2024
Q2 | $278K | Sell |
307
-9
| -3% | -$8.15K | 0.06% | 88 |
|
2024
Q1 | $246K | Sell |
316
-623
| -66% | -$485K | 0.05% | 82 |
|
2023
Q4 | $547K | Sell |
939
-10
| -1% | -$5.83K | 0.13% | 65 |
|
2023
Q3 | $510K | Sell |
949
-45
| -5% | -$24.2K | 0.13% | 65 |
|
2023
Q2 | $466K | Sell |
994
-60
| -6% | -$28.1K | 0.11% | 68 |
|
2023
Q1 | $362K | Sell |
1,054
-30
| -3% | -$10.3K | 0.09% | 72 |
|
2022
Q4 | $397K | Hold |
1,084
| – | – | 0.11% | 66 |
|
2022
Q3 | $351K | Sell |
1,084
-133
| -11% | -$43.1K | 0.11% | 66 |
|
2022
Q2 | $395K | Sell |
1,217
-30
| -2% | -$9.74K | 0.12% | 67 |
|
2022
Q1 | $357K | Sell |
1,247
-1,662
| -57% | -$476K | 0.09% | 75 |
|
2021
Q4 | $804K | Buy |
2,909
+300
| +11% | +$82.9K | 0.16% | 56 |
|
2021
Q3 | $603K | Buy |
2,609
+1,250
| +92% | +$289K | 0.12% | 63 |
|
2021
Q2 | $316K | Sell |
1,359
-59
| -4% | -$13.7K | 0.06% | 87 |
|
2021
Q1 | $265K | Sell |
1,418
-42
| -3% | -$7.85K | 0.06% | 98 |
|
2020
Q4 | $247K | Hold |
1,460
| – | – | 0.06% | 98 |
|
2020
Q3 | $216K | Hold |
1,460
| – | – | 0.06% | 99 |
|
2020
Q2 | $240K | Hold |
1,460
| – | – | 0.08% | 90 |
|
2020
Q1 | $203K | Sell |
1,460
-200
| -12% | -$27.7K | 0.07% | 99 |
|
2019
Q4 | $218K | Buy |
+1,660
| New | +$218K | 0.06% | 116 |
|